In Vivo and in Vitro Functions of Two Types of Mao

  • Jean C. Shih
  • Kevin Chen
Part of the Advances in Behavioral Biology book series (ABBI, volume 53)

Summary

Monoamine oxidase (MAO) A and B have selective substrate and inhibitor specificity. MAO A and B knock-out mice exhibit distinct neurotransmitter metabolism and behavior, suggesting that these two isoenzymes have distinct functions in vivo. These two isoenzymes are coded by different cDNAs with 70% amino acid identity. Interestingly, Isoleucine 335 in MAO A and the corresponding amino acid in MAO B, tyrosine 326, determine the substrate and inhibitor selectivity in vitro.

Keywords

Monoamine Oxidase Mitochondrial Monoamine Oxidase Norrie Disease Liver Monoamine Oxidase Inhibitor Clorgyline 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J.C. Shih, Molecular basis of human MAO A and B. Neuropsychopharmacology 4, 1–7 (1991).PubMedGoogle Scholar
  2. 2.
    J.P. Johnston, Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol. 17, 1285–1297 (1968).PubMedCrossRefGoogle Scholar
  3. 3.
    J. Knoll and K. Magyar, Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol. 5, 393–408 (1972).PubMedGoogle Scholar
  4. 4.
    J.C. Shih, K. Chen, and M. Ridd, Monoamine oxidases: from gene to behavior. Ann. Rev. Neuroscience 22, 197–217 (1999).CrossRefGoogle Scholar
  5. 5.
    A.R. Green and M.B.H. Youdim, Effects of monoamine oxidase inhibition by clorgyline, deprenyl or tranycypromine on 5-hydroxy-deprenyl or tranycypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration. Br. J. Pharmacol. 55, 415–422 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. New. Eng. J. 336, 1216–1222 (1997).CrossRefGoogle Scholar
  7. 7.
    A.W.J. Bach, N.C. Lan, D.L. Johnson, C.W. Abell, M.E. Bemkenek, S.-W. Kwan, P.H. Seeburg and J.C. Shih, cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. 85, 4934–4938 (1988).PubMedCrossRefGoogle Scholar
  8. 8.
    N.C. Lan, C. Heinzmann, A. Gal, I. Klisak, U. Orth, et. al., Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease. Genomics 4, 552–559 (1989).PubMedCrossRefGoogle Scholar
  9. 9.
    J. Grimsby, K. Chen, L.J. Wang, N.C. Lan and J.C. Shih, Human monoamine oxidase A and B gene exhibit identical exon-intron organization. Proc. Natl. Acad. Sci. USA 88, 3637–3641 (1991).PubMedCrossRefGoogle Scholar
  10. 10.
    O. Cases, I. Seif, J. Grimsby, P. Gaspar, K. Chen, et. al., Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO A. Science 268, 1763–1766 (1995).PubMedCrossRefGoogle Scholar
  11. 11.
    H.G. Brunner, M.R. Nelen, P. Van Zandvoort, N.G.G.M. Abeling, A.H. Van Gennip, et. al., X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am. J. Hum. Genet. 52, 1032–1039 (1994).Google Scholar
  12. 12.
    H.G. Brunner, M. Nelen, X.O. Breakefield, H.H. Ropers and B.A. Van Oost, Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578–580 (1993).PubMedCrossRefGoogle Scholar
  13. 13.
    J. Grimsby, M. Toth, K. Chen, T. Kumazawa, L. Klaidman, et. al., Increased stress response and β- phenylethylamine in MAO B-deficient mice. Nature Genet 17, 1–5 (1997).CrossRefGoogle Scholar
  14. 14.
    A.M. Cesura, J. Gottowik, H.-W. Lahm, G. Lang, R. Imhof, P. Malherbe, U. Röthlisberger and M. Da Prada, Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis. Eur. J. Biochem. 236, 996–1002 (1996).PubMedCrossRefGoogle Scholar
  15. 15.
    K. Chen, H.-F. Wu, and J.C. Shih, Influence of C Terminus on monoamine oxidase A and B catalytic activity. J. Neurochem. 66, 797–803 (1996).PubMedCrossRefGoogle Scholar
  16. 16.
    J. Gottowik, A.M. Cesura, P. Malherbe, G. Lang, and M. Da Prada, Characterization of wild-type and mutant forms of human monoamine oxidase A and B expressed in a mammalian cell line. FEBS Lett. 317, 152–156 (1993).PubMedCrossRefGoogle Scholar
  17. 17.
    J. Gottowik, P. Malherbe, G. Jang, M. Da Prada, and A.M. Cesura, Structure/function relationships of mitochondrial monoamine oxidase A and B chimeric forms. Eur. J. Biochem. 230, 934–942 (1995).PubMedCrossRefGoogle Scholar
  18. 18.
    Y. Tsugeno, I. Hirashiki, F. Ogata, and A. Ito, Regions of the molecule responsible for substrate specificity of monoamine oxidase A and B: a chimeric enzyme analysis. J. Biochem. (Tokyo), 118, 974–980 (1995).CrossRefGoogle Scholar
  19. 19.
    K. Chen, H.-F. Wu, J. Grimsby and J.C. Shih, Cloning of a novel monoamine oxidase (MAO) cDNA from trout liver. Mol. Pharm. 46:1226–1233 (1994).Google Scholar
  20. 20.
    J. Grimsby, M. Zentner and J.C. Shih: Identification of a region important for human monoamine oxidase B substrate and inhibitor selectivity. Life Sci. 58:777–787 (1996).PubMedCrossRefGoogle Scholar
  21. 21.
    H.-F. Wu, K. Chen, and J.C. Shih, Site-directed mutagenesis of monoamine oxidase A and B. Mol. Pharmacol. 43, 888–893 (1993).PubMedGoogle Scholar
  22. 22.
    R.M. Geha, K. Chen, and J.C. Shih, Phe208 and He199 in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat. J. Neurochem. 75, 1304–1309 (2000).PubMedCrossRefGoogle Scholar
  23. 23.
    Y. Tsugeno and A. Ito, A key amino acid responsible for substrate selectivity of monoamine oxidase A and B. J. Biol. Chem. 272, 14033–14036 (1997).PubMedCrossRefGoogle Scholar
  24. 24.
    R.M. Geha, I. Rebrin, K. Chen and J.C. Shih, Substrate and inhibitor specificities of human monoamine oxidase A and B are influenced by a single amino acid. J. Biol. Chem., 276, 9877–9882 (2001).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Jean C. Shih
    • 1
  • Kevin Chen
    • 2
  1. 1.Department of Molecular Pharmacology and Toxicology, School of Pharmacy and Department of Cell and Neurobiology, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA
  2. 2.Department of Molecular Pharmacology and Toxicology, School of PharmacyUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations